1-5 of 5
Babak Moghimi, MD
Close
Sort by
Journal Articles

Immune Tolerance Induction to Factor IX Through B Cell Gene Transfer – Delineating Between Tolerogenic and Immunogenic B Cells.

Xiaomei Wang, PhD, Babak Moghimi, MD, Irene Zolotukhin, M.S., Ou Cao, MD, PhD, Roland W Herzog, PhD
Journal: Blood
Blood (2012) 120 (21): 3156.
https://doi.org/10.1182/blood.V120.21.3156.3156
Published: 2012
Journal Articles

Tolerance Induction to B Domain-Deleted and Full-Length F.VIII by Co-Administration with Rapamycin

Babak Moghimi, MD, Brandon Sack, Ou Cao, MD, PhD, Roland W Herzog, PhD
Journal: Blood
Blood (2010) 116 (21): 21.
https://doi.org/10.1182/blood.V116.21.21.21
Published: 2010
Journal Articles

Anti-CD20 to Control Antibody Formation Against FVIII In Gene and Protein Replacement Therapy

Brandon Sack, BS, Babak Moghimi, MD, Barry Byrne, MD, PhD, Roland W Herzog, PhD
Journal: Blood
Blood (2010) 116 (21): 711.
https://doi.org/10.1182/blood.V116.21.711.711
Published: 2010
Journal Articles

Strategies to Prevent or Reverse Immune Responses Against Factor In Gene Replacement for Hemophilia B.

Sushrusha Nayak, PhD, Babak Moghimi, MD, Roland W Herzog, PhD
Journal: Blood
Blood (2010) 116 (21): 3761.
https://doi.org/10.1182/blood.V116.21.3761.3761
Published: 2010
Journal Articles

Oral Delivery of Bioencapsulated Factor IX Protects From Inhibitor Formation and Anaphylaxis in Protein Replacement Therapy for Hemophilia B.

Roland W. Herzog, PhD, Dheeraj Verma, PhD, Babak Moghimi, MD, Harminder D Singh, PhD, Paul A LoDuca, MD, Henry Daniell, PhD
Journal: Blood
Blood (2009) 114 (22): 222.
https://doi.org/10.1182/blood.V114.22.222.222
Published: 2009